Concepedia

Andrea Vaupel

AV

Statistics

Publications

28

Citations

1.3K

H-Index

20

Active since

1993

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Philipps University of Marburg

Bayer (Germany)

Bayer (Japan)

Andrea Vaupel is an author at Novartis (Switzerland) specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

1993–2022

28

Publications

28

Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C

Andreas Weiss, Edwige Lorthiois, Louise Barys et al. · Cancer Discovery · 2022 · 134 citations · Full text

, , +13

Stereoselective Synthesis of Heterocyclic Zinc Reagents via a Nickel-Catalyzed Radical Cyclization

Andrea Vaupel, Paul Knochel · The Journal of Organic Chemistry · 1996 · 117 citations

, , +14

JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRAS<sup>G12C</sup> for the Treatment of Solid Tumors

Edwige Lorthiois, Marc Gerspacher, Kim S. Beyer et al. · Journal of Medicinal Chemistry · 2022 · 95 citations · Full text

, , +17

Stereoselective Preparation of Polyfunctional Cyclopentane Derivatives by Radical Nickel‐ or Palladium‐Catalyzed Carbozincations

Heinz Stadtmüller, Andrea Vaupel, Charles E. Tucker et al. · Chemistry - A European Journal · 1996 · 85 citations

, , +10

Nickel-Catalyzed Preparations of Functionalized Organozincs

Stephan Vettel, Andrea Vaupel, Paul Knochel · The Journal of Organic Chemistry · 1996 · 81 citations

, , +15

1–5 of 28